What Is Ketamine Therapy for Depression?
Ketamine therapy is one of the most significant breakthroughs in depression treatment in decades. Originally developed as an anesthetic in the 1960s, ketamine has been shown in clinical research to produce rapid antidepressant effects, often within hours rather than the weeks required by traditional antidepressants like SSRIs and SNRIs.
For millions of people with treatment-resistant depression (TRD) -- those who have not responded adequately to two or more standard medications -- ketamine offers a fundamentally different approach. Rather than targeting serotonin or norepinephrine pathways, ketamine works on the glutamate system, promoting new neural connections and restoring brain plasticity.
A Brief History and FDA Context
In 2019, the FDA approved esketamine (brand name Spravato), a nasal spray derived from ketamine, for treatment-resistant depression. This was the first truly new mechanism of action for depression treatment in over 30 years. Spravato must be administered in a certified clinic under medical observation.
Meanwhile, off-label ketamine -- the racemic (original) form -- has been used by psychiatrists and clinics since the early 2000s. Off-label prescribing is legal and common in medicine. Many clinicians and researchers consider racemic ketamine to be as effective or more effective than esketamine alone, and it can be prescribed in oral, sublingual, IV, or intramuscular forms.
A landmark 2006 study published in Archives of General Psychiatry demonstrated that a single IV ketamine infusion produced rapid antidepressant effects within 2 hours in patients with treatment-resistant depression. Subsequent meta-analyses have confirmed response rates of 60-70% in TRD patients.
Who Is Ketamine Therapy For?
Ketamine therapy is generally considered for adults who:
- Have been diagnosed with major depressive disorder (MDD) or treatment-resistant depression
- Have tried at least two antidepressant medications without adequate relief
- Experience severe depressive symptoms that significantly impair daily functioning
- Are seeking faster-acting treatment than traditional antidepressants can provide
- May also have co-occurring anxiety, PTSD, or chronic pain conditions
Ketamine is not appropriate for everyone. People with a history of psychosis, uncontrolled hypertension, active substance use disorders involving ketamine, or certain other conditions may not be candidates. A thorough medical evaluation is always required before starting treatment.
How Effective Is Ketamine for Depression?
The clinical evidence for ketamine in depression treatment is substantial and growing:
- Rapid onset: Many patients report improvement within hours to days, compared to 4-8 weeks for SSRIs
- High response rates: Studies show 60-70% of treatment-resistant depression patients respond to ketamine
- Sustained benefit: With ongoing maintenance therapy, many patients maintain their improvement over months and years
- Complementary: Ketamine can be used alongside existing antidepressants and psychotherapy
It is important to set realistic expectations. Ketamine is not a cure for depression, and it does not work for everyone. Ongoing treatment, often combined with therapy, is typically needed to maintain benefits. Learn more about the science behind how ketamine works.
Your Treatment Options: Clinic vs At-Home
Patients seeking ketamine therapy in 2026 have two primary paths:
In-Clinic Treatment
IV infusions or Spravato (esketamine nasal spray) administered in a medical setting. Typical cost: $400-$800 per session for IV infusions. Spravato may be partially covered by insurance. Best for patients who want maximum medical supervision or have not responded to oral/sublingual forms.
At-Home Oral/Sublingual Therapy
Prescribed oral or sublingual ketamine tablets taken at home under telehealth supervision. Typical cost: $124-$300 per month depending on provider. Best for patients who want convenience, lower cost, and sustained daily or regular dosing. Read our detailed comparison of at-home vs clinic treatment.
Top Ketamine Provider for Depression Patients
After evaluating cost, dose flexibility, medical oversight, and patient accessibility, our top recommendation for at-home ketamine therapy is:
Kalm Health
- $124/month -- the most affordable ongoing treatment plan available
- $0 initial consultation -- no upfront cost to get evaluated
- No dose cap -- providers can adjust your dose based on clinical response, critical for treatment-resistant cases
- Higher-dose plan available: $174 every two months for patients who need more
- Licensed clinicians manage your care with regular follow-ups
For depression patients specifically, the lack of an arbitrary dose ceiling is a meaningful clinical advantage. Treatment-resistant depression often requires dose optimization that other providers restrict.
See our full provider comparison for depression patients to evaluate all major options.
Understanding the Costs
Cost is one of the biggest barriers to ketamine therapy. Here is a quick overview:
| Treatment Type | Typical Cost | Frequency |
|---|---|---|
| IV Infusion (clinic) | $400-$800/session | 6 sessions initial, then monthly |
| Spravato (clinic) | $600-$900/session before insurance | Twice weekly, then weekly/biweekly |
| At-Home (Kalm Health) | $124/month | Ongoing monthly |
| At-Home (other providers) | $200-$350/month | Ongoing monthly |
Learn more about insurance coverage and ways to reduce costs.
Ready to Explore Ketamine Therapy?
Kalm Health offers the most affordable path to ketamine treatment with no dose cap and a free initial consultation.
Learn More at Kalm Health